Results 131 to 140 of about 827 (180)

Successful Treatment of OXA-23 Acinetobacter baumannii Pneumonia with Sulbactam-Durlobactam in a Liver Transplant Recipient

Guangjiao Yin,1,2 Zhongzhong Liu,1,2 Zhen Fu,1,2 Zibiao Zhong,1,2 Shaojun Ye,1,2 Huaqin Pan1– 3 1Department of Organ Transplantation, Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Wuhan, 430071, People’s Republic of China; 2Department of Transplant Intensive Care Unit, Zhongnan Hospital of Wuhan ...
Yin,Guangjiao, Liu,Zhongzhong, Fu,Zhen, Zhong,Zibiao, Ye,Shaojun, Pan,Huaqin   +5 more
openaire   +1 more source

Successful Treatment with Sulbactam-Durlobactam for Severe Acute Pancreatitis Complicated by Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infection at Multiple Sites: A Case Report. [PDF]

Infect Drug Resist
Ge Z, Li L, Wang L, Liu D, Liu Y.
europepmc   +1 more source

Clinico-Microbiological Profile of Carbapenem-Resistant Acinetobacter baumannii Isolates From Intensive Care Unit Patients and In Vitro Activity of Sulbactam-Durlobactam: A Cross-Sectional Study From Eastern India. [PDF]

Cureus
Susanna A, Singh N, Verma G, Mohapatra I, Pradhan S, Panda SS, Prince B, Pattnaik D, Mishra PP.   +8 more
europepmc   +1 more source

Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria [PDF]

Diani E., Gaibani P., Gibellini D., Lewis R. E., Palombo M., Secci B.   +5 more
core   +1 more source

Activity of ampicillin-sulbactam, sulbactam-durlobactam, and comparators against <i>Acinetobacter baumannii-calcoaceticus</i> complex strains isolated from respiratory and bloodstream sources: results from ACNBio study. [PDF]

Antimicrob Agents Chemother
Buyukyanbolu E, Argotsinger J, Beck ET, Chamberland RR, Clark AE, Daniels AR, Liesman R, Fisher M, Gialanella P, Hand J, Harrington AT, Humphries RM, Huse H, Hamilton-Seth R, Hankins JD, Kufel WD, Riddell SW, Marino J, Westblade LF, Mochon AB, Narayanan N, Kirn TJ, Pierce VM, Potula R, Tekle T, Simner PJ, Tibbetts RJ, Vu C, Abbo LM, Martinez O, Dumm RE, Nicolau DP, Asempa TE, Acinetobacter baumannii Complex National Biorepository (ACNBio) Study Group.   +33 more
europepmc   +1 more source

Are cefiderocol or sulbactam/durlobactam better than alternative best available treatment for infection by carbapenem-resistant A. baumannii? A systematic literature review. [PDF]

Infection
Karakonstantis S, Ioannou P, Kofteridis DP.   +2 more
europepmc   +1 more source

A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of <i>Acinetobacter</i> spp. [PDF]

Antimicrob Agents Chemother
Veeraraghavan B, Shin E, Bakthavatchalam YD, Manesh A, Dubey D, Tascini C, Taracila MA, Hujer AM, Jacobs MR, Bonomo RA.   +9 more
europepmc   +1 more source

Sulbactam-durlobactam treatment for pulmonary infections caused by carbapenem-resistant Acinetobacter baumannii in lung transplant recipients

Journal of Infection
Piaopiao Zhang, Jing Wu, Yongshan Xu, Huqiang Wan, Jingyu Chen, Man Huang   +5 more
openaire   +2 more sources